Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell
Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing organization (cell and gene therapy CDMO). The acquisition, which was announced earlier this month, is said to position Catalent as a major technology, development, and manufacturing partner for […]